Alirocumab and Cardiovascular Outcomes in Older Patients After an Acute Coronary Syndrome: An ODYSSEY OUTCOMES Trial Analysis

被引：0
|
作者：
Sinnaeve, Peter R.
Schwartz, Gregory G.
Wojdyla, Daniel
Alings, Marco
Bittner, Vera A.
Bhatt, Deepak L.
Chiang, Chern-En
Diaz, Rafael
Dorobantu, Maria
Goodman, Shaun G.
Jukema, J. Wouter
Kim, Yong-Un
Pordy, Robert
Szarek, Michael
White, Harvey D.
Zeiher, Andreas M.
Steg, Philippe G.
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10795
引用
收藏
页数：3
相关论文
共 50 条
  • [21] EFFECTS OF ALIROCUMAB ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION: SUBANALYSIS FROM THE ODYSSEY OUTCOMES TRIAL
    Chiang, Chern-En
    Schwartz, Gregory
    Elbez, Yedid
    Bhatt, Deepak
    Bittner, Vera
    Diaz, Rafael
    Erglis, Andrejs
    Goodman, Shaun
    Hagstrom, Emil
    Harrington, Robert
    Jukema, Johan Wouter
    Liberopoulos, Evangelos
    Loy, Megan
    Pordy, Robert
    Szarek, Michael
    White, Harvey D.
    Zeiher, Andreas
    Simon, Tabassome
    Steg, Philippe Gabriel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 8 - 8
  • [22] Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial
    Lopes, Renato D.
    Guimaraes, Patr Icia O.
    Schwartz, Gregory G.
    Bhatt, Deepak L.
    Bittner, Vera A.
    Budaj, Andrzej
    Dalby, Anthony J.
    Diaz, Rafael
    Goodman, Shaun G.
    Harrington, Robert A.
    Jukema, J. Wouter
    Kiss, Robert Gabor
    Loy, Megan
    Pordy, Robert
    Poulouin, Yann
    Szarek, Michael
    White, Harvey D.
    Steg, Philippe Gabriel
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 (07) : 915 - 918
  • [23] Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
    Tunon, Jose
    Steg, Philippe Gabriel
    Bhatt, Deepak L.
    Bittner, Vera A.
    Diaz, Rafael
    Goodman, Shaun G.
    Jukema, J. Wouter
    Kim, Yong-Un
    Li, Qian H.
    Mueller, Christian
    Parkhomenko, Alexander
    Pordy, Robert
    Sritara, Piyamitr
    Szarek, Michael
    White, Harvey D.
    Zeiher, Andreas M.
    Schwartz, Gregory G.
    EUROPEAN HEART JOURNAL, 2020, 41 (42) : 4114 - 4123
  • [24] Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial
    Diaz, Rafael
    Li, Qian H.
    Bhatt, Deepak L.
    Bittner, Vera A.
    Baccara-Dinet, Marie T.
    Goodman, Shaun G.
    Jukema, J. Wouter
    Kimura, Takeshi
    Parkhomenko, Alexander
    Pordy, Robert
    Reiner, Zeljko
    Roe, Matthew T.
    Szarek, Michael
    Tse, Hung-Fat
    White, Harvey D.
    Zahger, Doron
    Zeiher, Andreas M.
    Schwartz, Gregory G.
    Steg, Ph Gabriel
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 33 - 43
  • [25] Relationship of Oxidized Phospholipids and Lp(a) to Outcomes after Acute Coronary Syndrome: A Post Hoc Analysis of the ODYSSEY OUTCOMES Trial
    Tsimikas, Sotirios
    Szarek, Michael
    Cobbaert, Christa
    Reijnders, Esther
    Jukema, J.
    Bhatt, Deepak
    Bittner, Vera
    Diaz, Rafael
    Fazio, Sergio
    Garon, Genevieve
    Chong, Yuan
    Gong, Xiaomin
    Goodman, Shaun
    Harrington, Robert
    White, Harvey
    Zeiher, Andreas
    Steg, Philippe
    Schwartz, Gregory
    CIRCULATION, 2024, 150
  • [26] The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial
    Karpov, Yuri A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2018, 14 (06) : 922 - 934
  • [27] Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial
    Szarek, Michael
    White, Harvey D.
    Schwartz, Gregory G.
    Alings, Marco
    Bhatt, Deepak L.
    Bittner, Vera A.
    Chiang, Chern-En
    Diaz, Rafael
    Edelberg, Jay M.
    Goodman, Shaun G.
    Hanotin, Corinne
    Harrington, Robert A.
    Jukema, J. Wouter
    Kimura, Takeshi
    Kiss, Robert Gabor
    Lecorps, Guillaume
    Mahaffey, Kenneth W.
    Moryusef, Angele
    Pordy, Robert
    Roe, Matthew T.
    Tricoci, Pierluigi
    Xavier, Denis
    Zeiher, Andreas M.
    Steg, Ph Gabriel
    CIRCULATION, 2018, 138
  • [28] Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
    Szarek, Michael
    White, Harvey D.
    Schwartz, Gregory G.
    Alings, Marco
    Bhatt, Deepak L.
    Bittner, Vera A.
    Diaz, Rafael
    Edelberg, Jay M.
    Goodman, Shaun G.
    Hanotin, Corinne
    Harrington, Robert A.
    Jukema, J. Wouter
    Kimura, Takeshi
    Kiss, Robert Gabor
    Lecorps, Guillaume
    Mahaffey, Kenneth W.
    Moryusef, Angele
    Pordy, Robert
    Roe, Matthew T.
    Tricoci, Pierluigi
    Xavier, Denis
    Zeiher, Andreas M.
    Steg, Gabriel
    Schwartz, Gregory G.
    Steg, Ph. Gabriel
    Bhatt, Deepak L.
    Bittner, Vera A.
    Diaz, Rafael
    Goodman, Shaun G.
    Harrington, Robert A.
    Jukema, J. Wouter
    Szarek, Michael
    Zeiher, Andreas M.
    Tricoci, Pierluigi
    Roe, Matthew T.
    Mahaffey, Kenneth W.
    Edelberg, Jay M.
    Hanotin, Corinne
    Lecorps, Guillaume
    Moryusef, Angele
    Pordy, Robert
    Sasiela, William J.
    Tamby, Jean-Francois
    Aylward, Philip E.
    Drexel, Heinz
    Sinnaeve, Peter
    Dilic, Mirza
    Gotcheva, Nina N.
    Goodman, Shaun G.
    Prieto, Juan-Carlos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (04) : 387 - 396
  • [29] Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
    Schwartz, Gregory G.
    Steg, Philippe Gabriel
    Szarek, Michael
    Bittner, Vera A.
    Diaz, Rafael
    Goodman, Shaun G.
    Kim, Yong-Un
    Jukema, J. Wouter
    Pordy, Robert
    Roe, Matthew T.
    White, Harvey D.
    Bhatt, Deepak L.
    CIRCULATION, 2020, 141 (20) : 1608 - 1617
  • [30] Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial (vol 140, pg 103, 2019)
    Steg
    CIRCULATION, 2019, 140 (04) : E171 - E171
12345